| Name | FAPI-4 |
| Description | FAPI-4 FAPI-4 is a fibroblast activating protein (FAP) inhibitor, a FAPI ligand, which shows strong liver uptake in PET imaging of primary liver cancer hepatocellular carcinoma (HCC) and is commonly used in PET imaging for the study of cancer. |
| In vivo | In 8-week-old BALB/c nu/nu mice inoculated with HT-1080-FAP cells, FAPI-4 (30 nmol per mouse; intravenous injection; once) revealed high overall tumor uptake[2]. |
| Storage | Keep away from direct sunlight,Store at low temperature,Store under nitrogen,
Store at -20°C
Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 3.3 mg/mL (3.78 mM), Sonication is recommended. DMSO : 80 mg/mL (91.65 mM), Sonication is recommended.
|
| Keywords | Fibroblast activation protein | FAPI-4 | FAPI4 | FAP |
| Inhibitors Related | Benzyl cinnamate | (9α,13α,14α)-4-Hydroxy-3,7-dimethoxy-7,8-didehydromorphinan-6-one | Pirazolac | Sodium Iodoacetate | Teneligliptin hydrobromide | Soquelitinib | Anti-inflammatory agent 36 | MG-T-19 | Anti-inflammatory agent 35 | Isoegomaketone | h-NTPDase-IN-3 | Complete Freund's adjuvant |
| Related Compound Libraries | Bioactive Compound Library | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Fluorochemical Library |